X-group (possible homology)

4011 beta-barrel domain in acetyl-CoA synthetase-like proteins

Ligands and drugs

1,263
Member domains
611
with ligand contacts (≤ 4 Å)
48.4% of members
441
with DrugDomain annotations
34.9% of members
253
with a DrugBank compound
20.0% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

89
Proteins with classified ligands
8
Superclasses bound (of 23)
4.4
Superclasses per 20 proteins
narrower than 88% of the 256 X-groups with enough proteins to compare (median 7.6)

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Nucleosides, nucleotides, and analogues8524.33.50×q < 0.0001
Homogeneous non-metal compounds1118.90.58×q = 0.06
Homogeneous metal compounds1843.10.42×q < 0.0001
Benzenoids16.40.16×q = 0.04
Organoheterocyclic compounds213.50.15×q = 4.4e-4
Organic oxygen compounds217.50.11×q < 0.0001
Organic acids and derivatives113.60.07×q < 0.0001
Lipids and lipid-like molecules09.80q = 1.7e-4
Organosulfur compounds11.80.55×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00131AMPAdenosine phosphate119
DB00171ATPATP30
DB03230PRXAdenosine-5'-Propylphosphate23
DB02596APCalpha,beta-Methyleneadenosine 5'-triphosphate13
DB16833ADPAdenosine disphosphate9
DB09459TLAL-tartaric acid5
DB01992COACoenzyme A2
DB02527CMPCyclic adenosine monophosphate2
DB03909ACPAdenosine-5'-[Beta, Gamma-Methylene]Triphosphate2
DB02175MLAMalonic acid1
DB03345BMEMercaptoethanol1
DB03376A5A5'-O-(N-(Alanyl)sulfamoyl)adenosine1

Most frequently bound compounds

PDB ligandNameDomains in contact
AMPADENOSINE MONOPHOSPHATE159
ATPADENOSINE-5'-TRIPHOSPHATE40
PRXADENOSINE-5'-MONOPHOSPHATE-PROPYL ESTER31
MGmetalMAGNESIUM ION29
ZNmetalZINC ION29
6R9[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] ethanoate22
CLCHLORIDE ION22
CAmetalCALCIUM ION20
ANPPHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER18
APCDIPHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER14
SLU5'-O-[N-(DEHYDROLUCIFERYL)-SULFAMOYL] ADENOSINE14
5SV[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl icosyl hydrogen phosphate10
SVS5'-deoxy-5'-({[2-(2-hydroxyphenyl)ethyl]sulfonyl}amino)adenosine10
WTA5'-O-[(S)-ethoxy(hydroxy)phosphoryl]adenosine10
3UK5'-O-[(S)-[(2-aminobenzoyl)oxy](hydroxy)phosphoryl]adenosine9
ADPADENOSINE-5'-DIPHOSPHATE9
NAmetalSODIUM ION9
YHF5'-O-[(S)-(cyclopentyloxy)(hydroxy)phosphoryl]adenosine9
YHQ5'-O-{(R)-hydroxy[(propan-2-yl)oxy]phosphoryl}adenosine9
YHT5'-O-{(S)-hydroxy[(prop-2-yn-1-yl)oxy]phosphoryl}adenosine9